Results 161 to 170 of about 939,843 (294)

Oxygen Consumption of Basal and Differentiating Cells from Hairless Mouse Epidermis

, 1969
Ole Didrik
openalex   +1 more source

Time, the final frontier

Molecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain, Michal Dibus, Omkar Joshi, Guillaume Jacquemet   +3 more
wiley   +1 more source

Metastatic basal cell carcinoma: Case series and literature review. [PDF]

Braz J Otorhinolaryngol
Rodrigues MG, de Lucena AV, Domingues GA, de Aquino CM, Otto DY, Bandiera de Oliveira Santos A, Kowalski LP.   +6 more
europepmc   +1 more source

An Electron Microscope Study of the Basal Cell Epithelioma

, 1962
Alvin S. Zelickson
openalex   +1 more source

The Syndrome of Jaw Cysts, Basal Cell Tumours and Skeletal Anomalies [PDF]

, 1964
R.A. Cawson, Gemma Kerr
openalex   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Chronic cutaneous melioidosis with concomitant basal cell carcinoma. [PDF]

IDCases
Barajas-Ochoa A, Reznicek J.
europepmc   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source

Optical super-high magnification dermoscopy versus standard dermoscopy in basal cell carcinoma. [PDF]

An Bras Dermatol
Amaral IMD, Maciel ES, Milheti DS, Seque CA, Enokihara MMSES, Hirata SH.   +5 more
europepmc   +1 more source

Surgical Management of Basal Cell Carcinoma of the Face [PDF]

, 1968
Dr R. L. Manchanda, Dr.R.P. Singh
openalex   +1 more source